Tonix Pharma (TNXP)
5.43
-0.35 (6.06%)
Upcoming Events
Latest Headlines
Tonix Pharma (TNXP) PT Lowered to $26 at Raymond James
October 20, 2026 6:35 AM - StreetInsider
Tonix to present TONMYA phase 3 data at pain congress
October 19, 2026 7:01 AM - StreetInsider
Tonix Pharmaceuticals to Present an Analysis of Phase 3 Data on TONMYA® at the IASP 2026 World Congress on Pain
October 19, 2026 7:00 AM - Globe NewsWire
Form 8-K Tonix Pharmaceuticals For: Oct 15
October 15, 2026 7:00 AM - SEC Filing
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Europe 2026
October 15, 2026 7:00 AM - Globe NewsWire
Form 8-K Tonix Pharmaceuticals For: Oct 01
October 2, 2026 5:20 PM - SEC Filing
Form 8-K Tonix Pharmaceuticals For: Sep 22
September 22, 2026 7:06 AM - SEC Filing
Tonix adds second Medicare payer deal for fibromyalgia drug Tonmya
September 22, 2026 7:03 AM - StreetInsider
Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement for TONMYA®
September 22, 2026 7:00 AM - Globe NewsWire
Raymond James Reiterates Strong Buy Rating on Tonix Pharma (TNXP)
September 22, 2026 5:06 AM - StreetInsider
Form 4 Tonix Pharmaceuticals For: Aug 20 Filed by: BAGGER RICHARD H
August 24, 2026 8:00 AM - SEC Filing
Tonix Pharma CEO named interim chief medical officer
August 18, 2026 4:01 PM - StreetInsider
Form 8-K Tonix Pharmaceuticals For: Aug 18
August 18, 2026 4:00 PM - SEC Filing
Form SCHEDULE 13G/A Tonix Pharmaceuticals Filed by: Sirenia Capital Management LP
August 14, 2026 8:36 AM - SEC Filing
Form SCHEDULE 13G Tonix Pharmaceuticals Filed by: AQR CAPITAL MANAGEMENT LLC
August 13, 2026 9:18 AM - SEC Filing
Tonix Pharma (TNXP) PT Raised to $27 at Raymond James
August 10, 2026 1:46 PM - StreetInsider
Form 10-Q Tonix Pharmaceuticals For: Jun 30
August 10, 2026 8:10 AM - SEC Filing
Form 8-K Tonix Pharmaceuticals For: Aug 10
August 10, 2026 7:16 AM - SEC Filing
Tonix Pharma (TNXP) Tops Q2 EPS by 27c
August 10, 2026 7:02 AM - StreetInsider
Tonix Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Highlights
August 10, 2026 7:00 AM - Globe NewsWire
Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences
August 5, 2026 7:00 AM - Globe NewsWire
Form 8-K Tonix Pharmaceuticals For: Aug 03
August 3, 2026 7:05 AM - SEC Filing
Tonix gets FDA alignment on Lyme disease antibody study design
August 3, 2026 7:00 AM - StreetInsider
Tonix Pharmaceuticals Announces Positive Minutes from Type C FDA Meeting to Discuss Adaptive Phase 2 Field Study of TNX-4800, a Human, anti-OspA Monoclonal Antibody, to Prevent Lyme Disease in the U.S
August 3, 2026 7:00 AM - Globe NewsWire
Tonix Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 10, 2026
July 27, 2026 7:00 AM - Globe NewsWire
Full Article List
